US regulators say the rare eye condition NAION can cause permanent vision loss. All GLP-1 drugs, including Ozempic and Wegovy, will now carry the warning.
Ozempic, Wegovy and other GLP-1 drugs to carry vision loss warning after FDA finds rare eye risk
